This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Haywood, G. A. Articles by McKenna, W. J. Search for Related Content PubMed PubMed Citation Articles by Haywood, G. A. Articles by McKenna, W. J.

Circulation, Vol 86, 896-902, Copyright © 1992 by American Heart Association

ARTICLES

Adenosine infusion for the reversal of pulmonary vasoconstriction in biventricular failure. A good test but a poor therapy

GA Haywood, JF Sneddon, Y Bashir, SH Jennison, HH Gray and WJ McKenna
Department of Cardiological Sciences, St. George's Hospital Medical School, London, UK.

BACKGROUND. Elevation of pulmonary vascular resistance is an important determinant of right ventricular function in patients with end-stage biventricular heart failure. Vasodilator drug therapy directed at the pulmonary vasculature is used in the hemodynamic assessment of patients for orthotopic heart transplantation, and therapy aimed at decreasing pulmonary vascular resistance and transpulmonary pressure gradient has been advocated in patients awaiting heart transplantation. Adenosine infusion has been shown to cause selective pulmonary vasodilatation in normal subjects and in patients with primary pulmonary hypertension but has not been assessed in patients with biventricular heart failure. METHODS AND RESULTS. Using two infusion doses, we studied the pulmonary and renal hemodynamic effects of adenosine on patients referred for heart transplantation (n = 21) and compared it with sodium nitroprusside (n = 18). Patients received 30% oxygen via face mask throughout the study. Adenosine at 100 micrograms/kg min achieved the same percentage fall in pulmonary vascular resistance as nitroprusside (41 +/- 6% versus 42 +/- 4%) and a greater and more consistent fall in transpulmonary pressure gradient (35 +/- 6% versus 9 +/- 30%, p less than 0.02). The mean arterial blood pressure fell by 16 mm Hg with nitroprusside but was unchanged by adenosine, indicating that in contrast to nitroprusside, adenosine acted as a selective pulmonary vasodilator. Despite this, cardiac index showed only a modest increase with adenosine (1.73 +/- 0.09 to 1.89 +/- 0.16 l.m-2, p less than 0.05), and there was a rise in pulmonary capillary wedge pressure from baseline at the higher dose (29.7 +/- 2.5 to 33.4 +/- 3.4 mm Hg, p less than 0.05). Renal blood flow was unchanged during adenosine infusion. CONCLUSIONS. Adenosine is a potent selective pulmonary vasodilator in patients with biventricular heart failure and is preferable to sodium nitroprusside as a test for the reversibility of pulmonary vasoconstriction. However, its deleterious effects on left atrial pressure make it unsuitable as a therapeutic agent in patients awaiting heart transplantation.

This article has been cited by other articles:

				B. Stobierska-Dzierzek, H. Awad, and R. E. Michler The evolving management of acute right-sided heart failure in cardiac transplant recipients J. Am. Coll. Cardiol., October 1, 2001; 38(4): 923 - 931. [Abstract] [Full Text] [PDF]

				E. P. Chen, H. B. Bittner, R. D. Davis Jr, and P. Van Trigt III Milrinone Improves Pulmonary Hemodynamics and Right Ventricular Function in Chronic Pulmonary Hypertension Ann. Thorac. Surg., March 1, 1997; 63(3): 814 - 821. [Abstract] [Full Text]

				M. Packer, C. M. O'Connor, J. K. Ghali, M. L. Pressler, P. E. Carson, R. N. Belkin, A. B. Miller, G. W. Neuberg, D. Frid, J. H. Wertheimer, et al. Effect of Amlodipine on Morbidity and Mortality in Severe Chronic Heart Failure N. Engl. J. Med., October 10, 1996; 335(15): 1107 - 1114. [Abstract] [Full Text] [PDF]

				D. A. Fullerton, S. D. Jones, F. L. Grover, and R. C. McIntyre Jr Adenosine Effectively Controls Pulmonary Hypertension After Cardiac Operations Ann. Thorac. Surg., April 1, 1996; 61(4): 1118 - 1123. [Abstract] [Full Text]

				M. R. Costanzo, S. Augustine, R. Bourge, M. Bristow, J. B. O'Connell, D. Driscoll, and E. Rose Selection and Treatment of Candidates for Heart Transplantation : A Statement for Health Professionals From the Committee on Heart Failure and Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association Circulation, December 15, 1995; 92(12): 3593 - 3612. [Abstract] [Full Text]

				A. Nussbacher, S. Arie, R. Kalil, P. Horta, M. D. Feldman, G. Bellotti, F. Pileggi, M. Ellis, W. H. Johnson, G. B. Camarano, et al. Mechanism of Adenosine-Induced Elevation of Pulmonary Capillary Wedge Pressure in Humans Circulation, August 1, 1995; 92(3): 371 - 379. [Abstract] [Full Text]